Jessica Wenthe from Uppsala University presented Lokon Pharma's research at the European Society for Medical Oncology (ESMO) in Munich and was awarded the Best Poster in the immunotherapy session. Congratulations Jessica!
April 27, 2018
The first patient has been enrolled in the LOAd703 clinical trial in Sweden, LOKON002, for the treatment of pancreatic, biliary, colorectal, and ovarian cancer.
December 2, 2016
Our LOAd703 clinical trial in LOKON001 for patients with pancreatic cancer in Houston, TX, USA has now enrolled their first patient!
